GNE myopathy
- Review and support for the development of a FDA dossier in patients with GNE Myopathy
- Development of a manuscript describing the GNE Myopathy Functional Activity Scale (GNEM-FAS) validation
- Development of a user manual for the GNEM-FAS validation
- Analysis of the GNEM-FAS validation
- Support for translations of the GNEM-FAS
- Post-hoc analyses to aid interpretation of change in GNE Myopathy endpoints including the primary endpoint of the strength composite score
Related categories
Experience, Musculoskeletal diseases, Orphan drugs, Special interest, Therapeutic area